A Resource for Healthcare and Social Services Professionals
Appropriate Use of Drug Testing in Clinical Addiction Medicine Consensus Document | ASAM
The American Society of Addiction Medicine (ASAM) created this document to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment, and promotion of recovery for patients with, or at risk for, addiction.
Visit webpagePharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings: Systematic Review Update | Effective Health Care Program | AHQR
Visit webpagePharmacotherapy for Opioid Use Disorder
Please visit SAMHSA's TIP 63: Medications for Opioid Use Disorder Executive Summary page ES-6.
Visit webpagePractice Guidance: Drug Screening as a Treatment Tool
This Practice Guidance, issued by BSAS, explores the use of drug screening in substance use treatment, with particular attention to evidence of effectiveness and to tailoring care to the needs of the individual.
Download filePrescribe to Prevent: Naloxone prescribing
Visit webpagePrescription Drug Monitoring Programs (PDMPs) | CDC
Visit webpageA Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders: Practice and Policy Considerations for Child Welfare, Collaborating Medical, and Service Providers
This manual, published by SAMHSA, offers best practices to states, tribes, and local communities on collaborative treatment approaches for pregnant patients living with opioid use disorders, and the risks and benefits associated with medication treatment.
Visit webpageAcademy of Perinatal Harm Reduction
The Academy of Perinatal Harm Reduction is dedicated to improving the lives of pregnant and parenting individuals who use substances and offers evidence-based, stigma-free resources, education and support for patients and providers.
Visit webpageBoston Medical Center Project RESPECT Guidelines for Treating Opioid Use Disorder in Pregnant and Parenting Patients
These guidelines should be used to inform the treatment of pregnant and parenting patients with opioid use disorder at Boston Medical Center.
Visit webpageCare Coordination to Support Maternal-Infant Health | American Academy of Pediatrics
The American Academy of Pediatrics discusses the benefits of a family-centered approach to coordinating care with community-based providers to support healthy development. Watch the following two videos: Supporting Mothers During Recovery: The Pediatric Medical Home - Steven Chapman, MD, FAAP; Developmental Screening and Surveillance - Julia Richerson, MD, FAAP
Visit webpageClinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants
This Clinical Guide from SAMHSA provides comprehensive, national guidance for optimal management of pregnant and parenting individuals with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.
Visit webpageClinical Statement from BMC Regarding Formulation Change During Pregnancy
This statement, from Project RESPECT within Boston Medical Center, details the evidence-based practice of using the buprenorphine-naloxone films for pregnant patients instead of the buprenorphine monotherapy.
Download fileGuidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy
The World Health Organization developed these guidelines to enable professionals to assist individuals who are pregnant, or have recently had a child, and who use alcohol or drugs or who have a substance use disorder, to achieve healthy outcomes for themselves and their fetus or infant.
Visit webpageNOWS - Planning for Maternal and Infant Discharge | American Academy of Pediatrics
The American Academy of Pediatrics focuses on the benefits of early planning for delivery and hospital discharge to ensure a safe transition to community care. Watch the following two videos: Benefits of Long-term Medication Treatment for OUD - Ronald Iverson, MD, FACOG; Understanding NOWS - Davida Schiff, MD, MSc, FAAP
Visit webpageOpioid Use and Opioid Use Disorder in Pregnancy | Committee Opinion No. 711. American College of Obstetricians and Gynecologists
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists' Committee on Obstetric Practice in collaboration with committee members Maria A. Mascola, MD, MPH; Ann E. Borders, MD, MSc, MPH; and the American Society of Addiction Medicine member Mishka Terplan, MD, MPH.
Visit webpageOpioid Use and Pregnancy | American Academy of Pediatrics
The American Academy of Pediatrics exemplifies parent education messages pediatricians can offer to families. Watch the following two videos: Trauma-informed Care - Davida Schiff, MD, MSc, FAAP; Working with Family Strengths to Support Recovery - Steven Chapman, MD, FAAP
Visit webpagePregnancy and Substance Use: A Harm Reduction Toolkit
The Harm Reduction Coalition and the Academy of Perinatal Harm Reduction collaborated to create this toolkit for pregnant and parenting individuals who use drugs, their loved ones, and their service providers, with the goal of promoting the overall health and well-being of pregnant individuals who use substances and their families.
Visit webpageAccommodations and Compensatory Strategies For Cognitive Deficits Resulting from a Brain Injury
This document is a compilation of strategies, knowledge, and information collected by the Massachusetts Rehabilitation Commission (MRC). It is organized by cognitive deficit, followed by how the deficit may appear when interacting with an individual, and compensatory strategies/accommodations that may be helpful while working together.
Download fileAdolescent Substance Use, Addiction, and Treatment
This video, featuring BMC CATALYST Medical Director Dr. Sarah Bagley, explains why adolescents choose to use drugs and alcohol, the effects, and what providers and families can do to intervene. The video is from the Health and Human Services Office of Adolescent Health.
Bureau of Substance Addiction Services MAT Practice Guidance Summary for Adolescents
Visit webpageHELPS Brain Injury Screening Tool
This document, developed by the Massachusetts Rehabilitation Comission, offers guidance for completing the HELPS Brain Injuries Screening Tool, which was developed by M. Picard, D. Scarisbrick, R. Paluck, in 1991 at the International Center for the Disabled. This tool has been adopted widely used within the brain injury community to screen for all types of brain injuries in any setting within any population.
Download fileHuman Trafficking Guidebook
This comprehensive guidebook is from the Massachusetts Medical Society.
Download fileOpioid Use Among Adolescents & Young Adults: Toolkit for Pediatric & Primary Care Providers
This toolkit has been developed specifically for pediatric, primary care, and other health professionals treating adolescents and young adults within their medical practice. This resource was developed by the Massachusetts Bureau of Substance Addiction Services (BSAS).
Visit webpageRecovery-friendly Pediatric Care
The American Academy of Pediatrics shares a framework that supports birth parents with opioid use disorder (OUD) in their treatment and recovery. Watch the following two videos: Building a Therapeutic Alliance with Families in Recovery - Ronald Iverson, MD, FACOG; Eat, Sleep, Console - Julia Richerson, MD, FAAP
Visit webpage
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.